Table 2. Univariate analysis of survival on clinical and pathologic factors.
| Variables | Median survival (month) | Survival rate (%) | P value | |
|---|---|---|---|---|
| 6-month | 1-year | |||
| Gender | ||||
| Male | 9 | 66.7 | 27.8 | 0.09 |
| Female | 13 | 77.8 | 55.6 | |
| Age (year) | ||||
| <60 | 12 | 76.9 | 30.8 | 0.86 |
| ≥60 | 8 | 64.3 | 42.9 | |
| Location | ||||
| Esophagus | 12 | 75 | 40 | 0.30 |
| Stomach | 11 | 75 | 25 | |
| Colon | - | - | - | |
| Gallbladder | - | - | - | |
| Pancreas | - | - | - | |
| Tumor length (cm) | ||||
| <4.5 | 12 | 84.6 | 46.2 | 0.14 |
| ≥4.5 | 8 | 57.1 | 28.6 | |
| Histological homology | ||||
| Pure | 12 | 76 | 40 | 0.07 |
| Mixed | 6 | 0 | - | |
| TNM stage | ||||
| I | 13 | 90 | 60 | 0.02 |
| II | 12 | 70 | 40 | |
| III | 6 | 42.9 | 0 | |
| Lymph node involvement | ||||
| Yes | 8 | 54.6 | 27.3 | 0.41 |
| No | 12 | 81.3 | 43.8 | |
| Lymphatic vessel invasion | ||||
| Yes | 10 | 58.8 | 29.4 | 0.50 |
| No | 12.5 | 90 | 50 | |
| Therapy | ||||
| Surgery | 5 | 0 | 0 | <0.0001 |
| Surgery + chemotherapy | 12 | 86.4 | 45.5 | |